Susumu. Mitsutake, et.al., Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes., The Journal of biological chemistry, 2011, 286

http://rdf.ncbi.nlm.nih.gov/pubmed/21669879

Susumu. Mitsutake, et.al., Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes., The Journal of biological chemistry, 2011, 286

pubmed

BRC マウスの系統

http://purl.org/net/cito/citesAsAuthority

• B6.129S2-Sgms2<tm2Kenw>
  http://metadb.riken.jp/db/rikenbrc_mouse/RBRC03462
• B6.129S2-Sgms2<tm1Kenw>
  http://metadb.riken.jp/db/rikenbrc_mouse/RBRC03461

Class

http://purl.org/net/cito/citesAsAuthority

• B6.129S2-Sgms2<tm2Kenw>
  http://metadb.riken.jp/db/rikenbrc_mouse/RBRC03462
• B6.129S2-Sgms2<tm1Kenw>
  http://metadb.riken.jp/db/rikenbrc_mouse/RBRC03461

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased circulating free fatty acid level in RBRC03461
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1006142
• decreased circulating triglyceride level in RBRC03461
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1006144
• increased insulin sensitivity in RBRC03462
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1014348
• decreased epididymal fat pad weight in RBRC03461
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1006149
• abnormal cell physiology in RBRC03462
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1014350
• improved glucose tolerance in RBRC03462
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1014349
• abnormal circulating glucose level in RBRC03462
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1014344
• decreased susceptibility to hepatic steatosis in RBRC03462
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1014346
• increased insulin sensitivity in RBRC03461
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1006145
• abnormal cell physiology in RBRC03461
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1006147
• decreased susceptibility to diet-induced obesity in RBRC03462
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1014351
• increased circulating free fatty acid level in RBRC03462
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1014345
• decreased circulating triglyceride level in RBRC03462
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1014347
• improved glucose tolerance in RBRC03461
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1006146
• decreased susceptibility to diet-induced obesity in RBRC03461
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1006148
• abnormal circulating glucose level in RBRC03461
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1006141
• decreased epididymal fat pad weight in RBRC03462
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1014352
• decreased susceptibility to hepatic steatosis in RBRC03461
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1006143

article

http://www.w3.org/2000/01/rdf-schema#seeAlso

• [Blank]
• [Blank]

allele

http://purl.org/net/cito/citesAsAuthority

• Sgms2<tm1Kenw>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5292035

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• abnormal cell physiology_Sgms2<tm1Kenw>/Sgms2<tm1Kenw>
  http://metadb.riken.jp/0005621B6129S2Sgms2tm1KenwSgms2tm1KenwSgms2tm1KenwSgms2tm1Kenw
• decreased circulating triglyceride level_Sgms2<tm1Kenw>/Sgms2<tm1Kenw>
  http://metadb.riken.jp/0002644B6129S2Sgms2tm1KenwSgms2tm1KenwSgms2tm1KenwSgms2tm1Kenw
• decreased susceptibility to diet-induced obesity_Sgms2<tm1Kenw>/Sgms2<tm1Kenw>
  http://metadb.riken.jp/0005659B6129S2Sgms2tm1KenwSgms2tm1KenwSgms2tm1KenwSgms2tm1Kenw
• abnormal circulating glucose level_Sgms2<tm1Kenw>/Sgms2<tm1Kenw>
  http://metadb.riken.jp/0000188B6129S2Sgms2tm1KenwSgms2tm1KenwSgms2tm1KenwSgms2tm1Kenw
• decreased susceptibility to hepatic steatosis_Sgms2<tm1Kenw>/Sgms2<tm1Kenw>
  http://metadb.riken.jp/0002310B6129S2Sgms2tm1KenwSgms2tm1KenwSgms2tm1KenwSgms2tm1Kenw
• decreased epididymal fat pad weight_Sgms2<tm1Kenw>/Sgms2<tm1Kenw>
  http://metadb.riken.jp/0009289B6129S2Sgms2tm1KenwSgms2tm1KenwSgms2tm1KenwSgms2tm1Kenw
• increased insulin sensitivity_Sgms2<tm1Kenw>/Sgms2<tm1Kenw>
  http://metadb.riken.jp/0002891B6129S2Sgms2tm1KenwSgms2tm1KenwSgms2tm1KenwSgms2tm1Kenw
• improved glucose tolerance_Sgms2<tm1Kenw>/Sgms2<tm1Kenw>
  http://metadb.riken.jp/0005292B6129S2Sgms2tm1KenwSgms2tm1KenwSgms2tm1KenwSgms2tm1Kenw
• increased circulating free fatty acid level_Sgms2<tm1Kenw>/Sgms2<tm1Kenw>
  http://metadb.riken.jp/0001554B6129S2Sgms2tm1KenwSgms2tm1KenwSgms2tm1KenwSgms2tm1Kenw

article

http://www.w3.org/2000/01/rdf-schema#seeAlso

• [Blank]
• [Blank]